Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autopha

TARDBP · neurodegeneration · -
Composite
0.600
Price
$0.61
Evidence For
0
Evidence Against
0

## Mechanistic Overview Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome fusion starts from the claim that modulating TARDBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome fusion starts from the claim that modulating TARDBP within the disease context of neur

Cross-Seeding Prevention Strategy

TARDBP · neurodegeneration · mechanistic
Composite
0.689
Price
$0.65
Evidence For
0
Evidence Against
0

## Mechanistic Overview Cross-Seeding Prevention Strategy starts from the claim that modulating TARDBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The cross-seeding prevention strategy targets the pathological interaction between TAR DNA-binding protein 43 (TDP-43), encoded by TARDBP, and classical neurodegenerative disease proteins such as amyloid-beta (Aβ), tau, and alpha-synucle

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

TARDBPAutophagyProtein Aggregationneurodegeneration
Convergent signals
  • TARDBP recurs across 2 selected hypotheses with aligned directionality in autophagy, protein aggregation.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

3/11
dimensions won
Cytosolic TDP-43 aggregation sequesters
8/11
dimensions won
Cross-Seeding Prevention Strategy

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.55
0.72
Evidence
0.65
0.68
Novelty
0.70
0.55
Feasibility
0.55
0.64
Impact
0.62
0.71
Druggability
0.40
0.58
Safety
0.52
0.62
Competition
0.78
0.48
Data
0.68
0.75
Reproducible
0.60
0.59
KG Connect
0.50
0.79

Score Breakdown

DimensionCytosolic TDP-43 aggregation sCross-Seeding Prevention Strat
Mechanistic0.5500.720
Evidence0.6500.680
Novelty0.7000.550
Feasibility0.5500.640
Impact0.6200.710
Druggability0.4000.580
Safety0.5200.620
Competition0.7800.480
Data0.6800.750
Reproducible0.6000.590
KG Connect0.5000.788

Evidence

Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-

No evidence citations yet

Cross-Seeding Prevention Strategy

No evidence citations yet

Debate Excerpts

Cytosolic TDP-43 aggregation sequesters SNAP29 and

4 rounds · quality: 0.81

Theorist

# Therapeutic Hypotheses: Neuron-Specific Autophagy Defects in ALS --- ## Hypothesis 1: Axonal Transport Defect in Autophagosome Maturation **Title:** C9orf72 hexanucleotide expansion impairs retro...

Skeptic

# Critical Evaluation of ALS Neuron-Specific Autophagy Hypotheses --- ## Hypothesis 1: Axonal Transport Defect (C9orf72/RAB7/Dynein) ### Weak Links - **Causal direction ambiguous**: Axonal autophag...

Domain Expert

# Feasibility Assessment: ALS Neuron-Specific Autophagy Hypotheses --- ## Summary Comparison Matrix | Domain | H1: Axonal Transport (C9orf72/RAB7) | H2: OPTN/TBK1 Mitophagy | H3: TDP-43 SNARE Fusio...

Synthesizer

```json { "ranked_hypotheses": [ { "title": "VCP/p97 ATPase mutations impair extraction of ubiquitinated autophagy substrates, causing proteasome-autophagy flux obstruction", "descri...

Cross-Seeding Prevention Strategy

4 rounds · quality: 0.92

Theorist

# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...

Theorist

# Novel Therapeutic Hypotheses for RNA Binding Protein Dysregulation in Neurodegeneration ## 1. Stress Granule Phase Separation Modulators **Target:** G3BP1/2, TIA1, TIAR **Mechanism:** Pharmacologic...

Skeptic

# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...

Skeptic

# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses ## 1. Stress Granule Phase Separation Modulators **Specific Weaknesses:** - **Temporal specificity problem**: No evidence provided...

Price History Overlay

Knowledge Graph Comparison

Cytosolic TDP-43 aggregation sequesters

0 edges
Top Node Types
Top Relations

Cross-Seeding Prevention Strategy

72 edges
Top Node Types
gene58
hypothesis7
pathway6
protein1
Top Relations
co_discussed32
co_associated_with15
implicated_in7
participates_in4
regulates3

Pathway Diagrams

Curated mechanism pathway diagrams from expert analysis

Cross-Seeding Prevention Strategy

graph TD
    A["Cellular Stress Triggers"]
    B["TARDBP Gene Expression"]
    C["TDP-43 Protein Synthesis"]
    D["Nuclear TDP-43 Function"]
    E["Cytoplasmic TDP-43 Mislocalization"]
    F["TDP-43 Conformational Change"]
    G["Beta-Sheet Formation"]
    H["Cross-Seeding with Amyloid-beta"]
    I["Cross-Seeding with Tau Protein"]
    J["Cross-Seeding with Alpha-Synuclein"]
    K["Heterotypic Protein Aggregates"]
    L["Neuronal Dysfunction"]
    M["Synaptic Loss"]
    N["Neurodegeneration"]
    O["RNA Splicing Modulators"]
    P["Protein Disaggregation Therapy"]

    A -->|"induces"| B
    B -->|"transcribes"| C
    C -->|"maintains"| D
    A -->|"disrupts"| E
    C -->|"mislocalizes"| E
    E -->|"triggers"| F
    F -->|"promotes"| G
    G -->|"initiates"| H
    G -->|"initiates"| I
    G -->|"initiates"| J
    H -->|"forms"| K
    I -->|"forms"| K
    J -->|"forms"| K
    K -->|"causes"| L
    L -->|"leads to"| M
    M -->|"results in"| N
    O -->|"prevents"| E
    P -->|"dissolves"| K

    classDef mechanism fill:#4fc3f7
    classDef pathology fill:#ef5350
    classDef therapy fill:#81c784
    classDef outcome fill:#ffd54f
    classDef genetics fill:#ce93d8

    class A,F,G mechanism
    class E,H,I,J,K,L pathology
    class O,P therapy
    class M,N outcome
    class B,C,D genetics